{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:55:46Z","timestamp":1791888946033,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Matrix Biology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.matbio.2004.09.007","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T19:01:49Z","timestamp":1103137309000},"page":"421-432","source":"Crossref","is-referenced-by-count":466,"title":["Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice"],"prefix":"10.1016","volume":"23","author":[{"given":"Despina","family":"Sitara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Razzaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Hesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbiah","family":"Yoganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold G.","family":"Erben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"J+APw-ppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Lanske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.matbio.2004.09.007_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. The ADHR Consortium","volume":"26","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.matbio.2004.09.007_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM197601222940402","article-title":"The dialysis encephalopathy syndrome. Possible aluminum intoxication","volume":"294","author":"Alfrey","year":"1976","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.matbio.2004.09.007_bib3","first-page":"1056","article-title":"The neutralization of FGF-23 ameliorates hypophosphatemia and rickets in Hyp mice","volume":"18","author":"Aono","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2004.09.007_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/geno.2001.6553","article-title":"Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone","volume":"74","author":"Argiro","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.matbio.2004.09.007_bib5","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1210\/me.2002-0113","article-title":"Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression","volume":"16","author":"Bai","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.matbio.2004.09.007_bib6","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.M210490200","article-title":"The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency","volume":"278","author":"Bai","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.matbio.2004.09.007_bib7","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23(R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.matbio.2004.09.007_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI18563","article-title":"Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent","volume":"112","author":"Berndt","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.matbio.2004.09.007_bib9","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0272-6386(00)70064-3","article-title":"Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management","volume":"35","author":"Block","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.matbio.2004.09.007_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium +ANc phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.matbio.2004.09.007_bib11","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1006\/bbrc.2001.5084","article-title":"FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate","volume":"284","author":"Bowe","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.matbio.2004.09.007_bib12","series-title":"Teratocarcinomas and Embryonic Stem Cells: A Practical Approach","first-page":"113","article-title":"Production and analysis of chimeric mice","author":"Bradley","year":"1987"},{"key":"10.1016\/j.matbio.2004.09.007_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/bj20030287","article-title":"Human recombinant PHEX has a strict S1+IDI specificity for acidic residues and cleaves peptides derived from FGF-23 and MEPE","volume":"373","author":"Campos","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.matbio.2004.09.007_bib14","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMe030037","article-title":"Oncogenic osteomalacia+IBQ-a complex dance of factors","volume":"348","author":"Carpenter","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.matbio.2004.09.007_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0272-6386(97)90009-3","article-title":"Poly(allylamine hydrochloride) (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure","volume":"29","author":"Chertow","year":"1997","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.matbio.2004.09.007_bib16","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1053\/ajkd.2001.27392","article-title":"Cardiovascular disease in end-stage renal disease patients","volume":"38","author":"Collins","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.matbio.2004.09.007_bib17","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1359\/jbmr.2002.17.6.1102","article-title":"Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism","volume":"17","author":"De Beur","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2004.09.007_bib18","series-title":"Principles in Bone Biology","first-page":"321","article-title":"Phosphorus homeostasis and related disorders","author":"Drezner","year":"2002"},{"key":"10.1016\/j.matbio.2004.09.007_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/geno.1996.0421","article-title":"cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone","volume":"36","author":"Du","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.matbio.2004.09.007_bib20","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1210\/en.2004-0354","article-title":"Fibroblast growth factor 23: a phosphatonin regulating phosphate homeostasis?","volume":"145","author":"Dunstan","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.matbio.2004.09.007_bib21","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1172\/JCI119809","article-title":"Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13","volume":"100","author":"Econs","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.matbio.2004.09.007_bib22","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca +ANc PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.matbio.2004.09.007_bib23","first-page":"790","article-title":"Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets","volume":"60","author":"Holm","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.matbio.2004.09.007_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets","volume":"11","author":"HYP_Consortium","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.matbio.2004.09.007_bib25","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1523-1755.2004.00604.x","article-title":"FGF-23 in patients with end-stage renal disease on hemodialysis","volume":"65","author":"Imanishi","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.matbio.2004.09.007_bib26","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.matbio.2004.09.007_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1101\/gad.8.3.277","article-title":"Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene","volume":"8","author":"Karaplis","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.matbio.2004.09.007_bib28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature01657","article-title":"Developmental regulation of the growth plate","volume":"423","author":"Kronenberg","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.matbio.2004.09.007_bib29","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1210\/en.139.12.5194","article-title":"The parathyroid hormone\/parathyroid hormone-related peptide receptor mediates actions of both ligands in murine bone","volume":"139","author":"Lanske","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.matbio.2004.09.007_bib30","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.matbio.2004.09.007_bib31","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of the {alpha}1(I) collagen promoter exhibit growth retardation, osteomalacia and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.matbio.2004.09.007_bib32","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","author":"Liu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.matbio.2004.09.007_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00335-003-2310-z","article-title":"New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice","volume":"15","author":"Lorenz-Depiereux","year":"2004","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.matbio.2004.09.007_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/tera.1420220306","article-title":"Differential staining of cartilage and bone in whole fetuses by alcian blue and alizarin red S","volume":"22","author":"McLeod","year":"1980","journal-title":"Teratology"},{"key":"10.1016\/j.matbio.2004.09.007_bib36","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0272-6386(12)80059-X","article-title":"Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy","volume":"16","author":"Meric","year":"1990","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.matbio.2004.09.007_bib37","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1210\/en.142.2.926","article-title":"Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition","volume":"142","author":"Miao","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.matbio.2004.09.007_bib38","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-021919","article-title":"Clinical case seminar: fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia","volume":"88","author":"Nelson","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.matbio.2004.09.007_bib39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM198209163071202","article-title":"The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy","volume":"307","author":"Ott","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.matbio.2004.09.007_bib40","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00016.2003","article-title":"FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization","volume":"285","author":"Quarles","year":"2003","journal-title":"Am. J. Physiol: Endocrinol. Metab."},{"key":"10.1016\/j.matbio.2004.09.007_bib41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.matbio.2004.09.007_bib42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bone.2003.10.005","article-title":"MEPE has the properties of an osteoblastic phosphatonin and minhibin","volume":"34","author":"Rowe","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.matbio.2004.09.007_bib43","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1074\/jbc.M207872200","article-title":"Human fibroblast growth factor-23 mutants suppress Na+--dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production","volume":"278","author":"Saito","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.matbio.2004.09.007_bib44","series-title":"Methods of Calcified Tissue Preparation","first-page":"1","article-title":"Preparation of calcified tissues for light microscopy","author":"Schenk","year":"1984"},{"key":"10.1016\/j.matbio.2004.09.007_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00355.x","article-title":"The phosphatonin pathway: new insights in phosphate homeostasis","volume":"65","author":"Schiavi","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.matbio.2004.09.007_bib46","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","article-title":"Octreotide therapy for tumor-induced osteomalacia","volume":"345","author":"Seufert","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.matbio.2004.09.007_bib47","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.matbio.2004.09.007_bib48","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/en.143.8.3179","article-title":"Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo","volume":"143","author":"Shimada","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.matbio.2004.09.007_bib49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.matbio.2004.09.007_bib50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type Iia","volume":"314","author":"Shimada","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.matbio.2004.09.007_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198607173150304","article-title":"Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis","volume":"315","author":"Slatopolsky","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.matbio.2004.09.007_bib52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1523-1755.1999.00240.x","article-title":"RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group","volume":"55","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.matbio.2004.09.007_bib53","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1073\/pnas.11154898","article-title":"FGF23, hypophosphatemia, and rickets: has phosphatonin been found?","volume":"98","author":"Strewler","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.matbio.2004.09.007_bib54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/hmg\/6.2.165","article-title":"Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia","volume":"6","author":"Strom","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.matbio.2004.09.007_bib55","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/ndt\/14.2.333","article-title":"X-linked hypophosphataemia: a homologous disorder in humans and mice","volume":"14","author":"Tenenhouse","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.matbio.2004.09.007_bib56","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","article-title":"Serum FGF23 levels in normal and disordered phosphorus homeostasis","volume":"18","author":"Weber","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.matbio.2004.09.007_bib57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jc.86.2.497","article-title":"The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting","volume":"86","author":"White","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.matbio.2004.09.007_bib58","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM200201313460521","article-title":"Case 29-2001: oncogenic hypophosphatemic osteomalacia","volume":"346","author":"White","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.matbio.2004.09.007_bib59","first-page":"E 700","article-title":"Intrinsic mineralization defect in hyp mouse osteoblasts","volume":"38","author":"Xiao","year":"1998","journal-title":"Am. J. Physiol: Endocrinol. Metab."},{"key":"10.1016\/j.matbio.2004.09.007_bib60","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.matbio.2004.09.007_bib61","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Matrix Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X04001155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X04001155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T10:19:48Z","timestamp":1625134788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0945053X04001155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0945053X04001155"],"URL":"https:\/\/doi.org\/10.1016\/j.matbio.2004.09.007","relation":{},"ISSN":["0945-053X"],"issn-type":[{"value":"0945-053X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}